VANCOUVER, March 2, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: IMH; OTC: IVITF; FRA: 8IS)is pleased to announce that it has closed its previously announced bought deal private placement (the "Offering"), with Canaccord Genuity Corp. and Eventus Capital Corp. (collectively, the "Underwriters"), including a portion of the over-allotment
Each Unit is comprised of one common share and one half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant is exercisable to acquire one common share (a "Warrant Share") until September 2, 2018 at an exercise price of $2.35 per Warrant Share. The Warrants are subject to an acceleration provision that allows the Company to give notice of an earlier expiry date if the Company's daily volume weighted average share price on the Canadian Securities Exchange (or such other stock exchange the Company may be trading on) is greater than $3.75 for 10 consecutive trading days.
Net proceeds from the Offering will be used for expansion plans for the Company's assets and for general working capital purposes. As compensation, the Underwriters received a commission of 7% of the gross proceeds raised which was paid partly in cash and partly through the issuance of 281,818 Units having the same terms as the Units issued to purchasers. The Company also issued to the Underwriters a total of 688,039 Underwriters' warrants. Each Underwriters' warrant is exercisable to acquire one common share at a price of $1.65 until September 2, 2018.
All securities issued or issuable under the Offering are subject to a four-month hold period expiring on July 3, 2017.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,Dan KriznicChairman & CEO604-368-6437
Larry HeinzlmeirVice President, Marketing & Communications604-537-8676
SOURCE Invictus MD Strategies
Subscribe to our Free Newsletters!
Cardiopulmonary bypass is a technique which allows performing open heart surgical procedures in a ...
Acyclovir is an effective antiviral medication used primarily for treating the symptoms of herpes ...
Fasciotomy is a surgical procedure where the fascia is incised to relieve the compartmental ...View All